Sumangala Agri Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 4.00 M
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.50 Cr
- Revenue Growth 220.58%
- Profit Growth 10.88%
- Ebitda 112.37%
- Net Worth 1.90%
- Total Assets -3.53%
About Sumangala Agri Biotech
Sumangala Agri Biotech Private Limited (SABPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 December 2011 and has a history of 13 years and two months. Its registered office is in Guntur, Andhra Pradesh, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹1.50 Cr.
Shiva Danda and Danda Rao serve as directors at the Company.
Company Details
- Location
Guntur, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01407AP2011PTC078290
- Company No.
078290
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 2011
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Sumangala Agri Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shiva Danda  | Director | 28-Dec-2011 | Current |
| Danda Rao | Director | 28-Dec-2011 | Current |
Financial Performance of Sumangala Agri Biotech.
Sumangala Agri Biotech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 220.58% increase. The company also saw a substantial improvement in profitability, with a 10.88% increase in profit. The company's net worth moved up by a moderate rise of 1.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sumangala Agri Biotech?
In 2019, Sumangala Agri Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹15.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2013 | Others | ₹1.50 Cr | Open |
How Many Employees Work at Sumangala Agri Biotech?
Unlock and access historical data on people associated with Sumangala Agri Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sumangala Agri Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sumangala Agri Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.